Verastem Oncology Announces Pricing of Registered Direct Offering of $150 Million of Convertible Notes

World News: . []

Verastem Inc Nasdaq VSTM (Verastem Oncology or the Company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the pricing of an offe ring of...

More news and information about Verastem, Inc.

Published By:

Business Wire: 00:35 GMT Friday 12th October 2018

Published: .

Search for other references to "verastem" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us